Unleashing the potential of NOD-and Toll-like agonists as vaccine adjuvants

C Maisonneuve, S Bertholet… - Proceedings of the …, 2014 - National Acad Sciences
Innate immunity confers an immediate nonspecific mechanism of microbial recognition
through germ line-encoded pattern recognition receptors (PRRs). Of these, Toll-like …

Vaccines: past, present and future

SA Plotkin - Nature medicine, 2005 - nature.com
The vaccines developed over the first two hundred years since Jenner's lifetime have
accomplished striking reductions of infection and disease wherever applied. Pasteur's early …

Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming

A Martín-Fontecha, LL Thomsen, S Brett, C Gerard… - Nature …, 2004 - nature.com
Naive T cells are stimulated by antigen-presenting dendritic cells (DCs) in secondary
lymphoid organs, but whether other types of cell participate in T cell priming is unclear. Here …

Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants

X Wan, Y Yin, C Zhou, L Hou, Q Cui, X Zhang… - Carbohydrate …, 2022 - Elsevier
Adjuvants have been used in vaccines for a long time to promote the body's immune
response, reducing vaccine dosage and production costs. Although many vaccine adjuvants …

The perfect mix: recent progress in adjuvant research

B Guy - Nature reviews microbiology, 2007 - nature.com
Developing efficient and safe adjuvants for use in human vaccines remains both a challenge
and a necessity. Past approaches have been largely empirical and generally used a single …

Adjuvants for animal vaccines

Y Burakova, R Madera, S McVey, JR Schlup… - Viral immunology, 2018 - liebertpub.com
Vaccines are essential tools for the prevention and control of infectious diseases in animals.
One of the most important steps in vaccine development is the selection of a suitable …

Cationic liposomal lipids: from gene carriers to cell signaling

C Lonez, M Vandenbranden, JM Ruysschaert - Progress in lipid research, 2008 - Elsevier
Cationic lipids are positively charged amphiphilic molecules which, for most of them, form
positively charged liposomes, sometimes in combination with a neutral helper lipid. Such …

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

K Zaks, M Jordan, A Guth, K Sellins, R Kedl… - The Journal of …, 2006 - journals.aai.org
Complexing TLR9 agonists such as plasmid DNA to cationic liposomes markedly
potentiates their ability to activate innate immunity. We therefore reasoned that liposomes …

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface …

P Vandepapelière, Y Horsmans, P Moris… - Vaccine, 2008 - Elsevier
A randomised, double-blind study assessing the potential of four adjuvants in combination
with recombinant hepatitis B surface antigen has been conducted to evaluate humoral and …

Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines

W Yan, W Chen, L Huang - Molecular immunology, 2007 - Elsevier
Cationic liposome has been effectively used as a delivery system for DNA and protein
vaccines. Recently, we discovered that strong anti-tumor immunity could be generated when …